Sign Up Now to Download a Free Research Report on

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts




Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

Opexa Therapeutics, Inc.

Opexa Therapeutics shares gained 23.70 percent on volume of over 5 million shares traded Tuesday to close at $2.61 a share. The company has eneterd into an option and license agreement with Merck Serono for the development of Tcelna for the treatment of multiple sclerosis.

Going forward ... (see research report)



RESEARCH REPORT ON Download Free Report Now


Preview Pages of Actual Equity Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on